PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis

Thomas Quéméneur1, Françoise Martin-Nizard, Abdelmejid Kandoussi

  • 1Department of Nephrology and Internal Medicine, Hospital of Valenciennes, Valenciennes, France.

Insights

Systemic vasculitis (SV) is linked to increased low-density lipoprotein (LDL) oxidation and reduced paraoxonase 1 (PON1) activity. This may accelerate atherosclerosis development in patients with SV.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Systemic vasculitis (SV) predisposes individuals to atherosclerosis.
  • High-density lipoprotein (HDL) plays a protective role against atherosclerosis through reverse cholesterol transport and by inhibiting low-density lipoprotein (LDL) oxidation, mediated by apolipoprotein A-I (Apo-AI) and paraoxonase 1 (PON1).

Purpose of the Study:

  • To investigate whether LDL oxidation is elevated in patients with SV.
  • To determine if reduced PON1 activity is associated with increased LDL oxidation in SV.

Main Methods:

  • Serum analysis of 33 active SV (ASV) patients, 32 remission SV (RSV) patients, and 20 healthy subjects (HS).
  • Measurements included C-reactive protein (CRP), lipids, lipoproteins, apolipoproteins, PON1 activity, LDL-immune complexes (LDL-IC), and autoantibodies to oxidized-LDL (ox-LDL).

Main Results:

  • CRP levels were higher in ASV patients compared to RSV and HS, correlating negatively with HDL-cholesterol and Apo-AI.
  • Autoantibodies to ox-LDL and malondialdehyde-LDL were elevated in RSV patients.
  • LDL-IC titers were higher in ASV patients, and PON1 activity was lower in both ASV and RSV patients compared to HS.

Conclusions:

  • Inflammatory markers in SV are associated with altered lipoprotein profiles.
  • This modification may lead to decreased PON1 activity, increased ox-LDL, and accelerated atherosclerosis in SV patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...